Frédéric Larbret

2.7k citations

32 papers · 2.1k · h-index 20

Impact in

Hematology top 1%
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Molecular Biology 16
- Glycosylation and Glycoproteins Research 3
- Metabolism, Diabetes, and Cancer 3
Immunology 10
- Immune Cell Function and Interaction 4

Co-authors: William Vainchenker (16 shared papers)Najet Debili (14 shared papers)Yann Lécluse (5 shared papers)Marcel Deckert (8 shared papers)Jérôme Larghero (5 shared papers)Kathiane Laurent (3 shared papers)Mireille Cormont (3 shared papers)Jean‐François Tanti (3 shared papers)
Journals: Blood (12 papers)Experimental Hematology (2 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: France United States Morocco

In The Last Decade

Frédéric Larbret

31 papers receiving 2.0k citations

Peers

Countries citing papers authored by Frédéric Larbret

Since Specialization

Citations

This map shows the geographic impact of Frédéric Larbret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Larbret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Larbret more than expected).

Fields of papers citing papers by Frédéric Larbret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Larbret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Larbret. The network helps show where Frédéric Larbret may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Larbret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Larbret Line = papers co-authored together Frédéric Larbret links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells Cancer Research ·Issam Ben Sahra, Kathiane Laurent, Sandy Giuliano, Frédéric Larbret, Gilles Ponzio, Pierre Gounon, Y. Le Marchand‐Brustel, Sophie Giorgetti‐Peraldi, Mireille Cormont, Corine Bertolotto, Marcel Deckert, Patrick Auberger, Jean‐François Tanti, Frédéric Bost	2010	453
2	Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling Blood ·Larissa Lordier, Abdelali Jalil, Frédéric Aurade, Frédéric Larbret, Jérôme Larghero, Najet Debili, William Vainchenker, Yunhua Chang	2008	155
3	The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera Blood ·Sabrina Dupont, Aline Massé, Chloé James, Irène Teyssandier, Yann Lécluse, Frédéric Larbret, Valérie Ugo, Patrick Saulnier, Serge Koscielny, J P Le Couedic, Nicole Casadevall, William Vainchenker, François Delhommeau	2007	148
4	Proplatelet formation is regulated by the Rho/ROCK pathway Blood ·Yunhua Chang, Frédéric Aurade, Frédéric Larbret, Yanyan Zhang, Jean‐Pierre Le Couedic, Laurence Momeux, Jérôme Larghero, Jacques Bertoglio, Fawzia Louache, Elisabeth M. Cramer, William Vainchenker, Najet Debili	2007	146
5	FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia Journal of Clinical Investigation ·Hana Raslová, Emiko Komura, J P Le Couedic, Frédéric Larbret, Najet Debili, Jean Feunteun, Olivier Danos, Olivier Albagli, William Vainchenker, Rémi Favier	2004	132
6	Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera Experimental Hematology ·Valérie Ugo, Christophe Marzac, Irène Teyssandier, Frédéric Larbret, Yann Lécluse, Najet Debili, William Vainchenker, Nicole Casadevall	2004	132
7	A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell–derived primitive hematopoiesis Blood ·Olena Klimchenko, Marcella Mori, Antonio DiStefano, Thierry Langlois, Frédéric Larbret, Yann Lécluse, Olivier Féraud, William Vainchenker, Françoise Norol, Najet Debili	2009	116
8	Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens Blood ·Maria Carmen Martínez, Frédéric Larbret, Fatiha Zobairi, Josée Coulombe, Najet Debili, William Vainchenker, Martial Ruat, J M Freyssinet	2006	111
9	Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach Blood ·Hana Raslová, Audrey Kauffmann, Dalila Sekkaı̈, Hugues Ripoche, Frédéric Larbret, Thomas Robert, Diana Tronik Le Roux, Guido Kroemer, Najet Debili, Philippe Dessen, Vladimir Lazar, William Vainchenker	2006	87
10	Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis Blood ·Ronan Chaligné, Chloé James, Carole Tonetti, Rodolphe Besancenot, J P Le Couedic, Fanny Fava, Frédéric Mazurier, Isabelle Godin, Karim Maloum, Frédéric Larbret, Yann Lécluse, William Vainchenker, Stéphane Giraudier	2007	77
11	Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway Oncogene ·Moeez Rathore, Christophe A. Girard, Mickaël Ohanna, Mélanie Tichet, Rania Ben Jouira, Esther García, Frédéric Larbret, Maéva Gesson, Stéphane Audebert, J.‐P. Lacour, Henri Montaudié, Virginie Prod’homme, Sophie Tartare‐Deckert, Marcel Deckert	2019	70
12	Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors Blood ·Stéphane Giraudier, Hédia Chagraoui, Emiko Komura, Stéphane Barnache, Benoı̂t Blanchet, Jean Pierre LeCouédic, David F. Smith, Frédéric Larbret, Anne‐Laure Taksin, Françoise Moreau-Gachelin, Nicole Casadevall, Michel Tulliez, Anne Hulin, Najet Debili, William Vainchenker	2002	68
13	Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma EMBO Molecular Medicine ·Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod’homme, Mickaël Ohanna, Ana Popović, Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stéphane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A. Girard, Marcel Deckert, Sophie Tartare‐Deckert	2021	50
14	A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma Cancer Research ·Christophe A. Girard, Margaux Lecacheur, Rania Ben Jouira, Ilona Berestjuk, Serena Diazzi, Virginie Prod’homme, Aude Mallavialle, Frédéric Larbret, Maéva Gesson, Sébastien Schaub, Sabrina Pisano, Stéphane Audebert, Bernard Mari, Cédric Gaggioli, Eleonora Leucci, Jean‐Christophe Marine, Marcel Deckert, Sophie Tartare‐Deckert	2020	44
15	Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression Experimental Hematology ·Emiko Komura, Hédia Chagraoui, Véronique Mansat‐ De Mas, Benoı̂t Blanchet, Paulo De Sepulveda, Frédéric Larbret, Jérôme Larghero, Michel Tulliez, Najet Debili, William Vainchenker, Stéphane Giraudier	2003	44
16	P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1 Blood ·Laure Gilles, Romain Guièze, Dominique Bluteau, Véronique Cordette-Lagarde, Catherine Lacout, Rémi Favier, Frédéric Larbret, Najet Debili, William Vainchenker, Hana Raslová	2008	42
17	CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver British Journal of Cancer ·Élodie Guillemot, B Karimdjee-Soilihi, Emmanuelle Pradelli, Maxime Benchetrit, Emilie Goguet, Millet Ma, Frédéric Larbret, Michiels Jf, D Birnbaum, P. Alemanno, Heidy Schmid‐Antomarchi, Annie Schmid‐Alliana	2012	40
18	Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process Blood ·Larissa Lordier, Yunhua Chang, Abdelali Jalil, Frédéric Aurade, Loïc Garçon, Yann Lécluse, Frédéric Larbret, Toshiyuki Kawashima, Toshio Kitamura, Jérôme Larghero, Najet Debili, William Vainchenker	2010	37
19	Inhibition of the GTPase Rac1 Mediates the Antimigratory Effects of Metformin in Prostate Cancer Cells Molecular Cancer Therapeutics ·Béatrice Dirat, Isabelle Ader, Muriel Golzio, Fabienne Massa, Amel Mettouchi, Kathiane Laurent, Frédéric Larbret, Bernard Malavaud, Mireille Cormont, Emmanuel Lemichez, Olivier Cuvillier, Jean‐François Tanti, Frédéric Bost	2014	34
20	A role for Peroxisome Proliferator-Activated Receptor Beta in T cell development Scientific Reports ·Isabelle Mothe‐Satney, Joseph Murdaca, Brigitte Sibille, Anne‐Sophie Rousseau, Raphaëlle Squillace, Gwenaëlle Le Menn, Akila Rekima, Frédéric Larbret, Juline Pelé, Valérie Verhasselt, Paul A. Grimaldi, Jaap G. Neels	2016	19

About Frédéric Larbret

Frédéric Larbret is a scholar working on Molecular Biology, Immunology, Hematology, Oncology and Genetics, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Eosinophilic Disorders and Syndromes (5 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Hematology (748 citations), Genetics (573 citations), Cancer Research (304 citations), Immunology and Allergy (107 citations) and Molecular Biology (1.0k citations). Frédéric Larbret has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include William Vainchenker, Najet Debili, Yann Lécluse, Marcel Deckert, Jérôme Larghero, Kathiane Laurent, Mireille Cormont, Jean‐François Tanti, Frédéric Bost and Yunhua Chang. Their work appears in journals such as Blood, Experimental Hematology, Frontiers in Immunology, Cancer Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Frédéric Larbret

Impact in

Papers in i

In The Last Decade

Frédéric Larbret

Peers

Countries citing papers authored by Frédéric Larbret

Fields of papers citing papers by Frédéric Larbret

All Works

About Frédéric Larbret

Explore authors with similar magnitude of impact

Papers in